Find Infliximab manufacturers, exporters & distributors on PharmaCompass

PharmaCompass

Synopsis

Synopsis

ACTIVE PHARMA INGREDIENTS

0

USDMF

0

CEP/COS

0

EU WC

0

KDMF

0

VMF

0INTERMEDIATES

REF. STANDARDS OR IMPURITIES

0

EDQM

0

USP

0

JP

0

Others

FDF Dossiers

DRUG PRODUCT COMPOSITIONS

0RELATED EXCIPIENT COMPANIES

0EXCIPIENTS BY APPLICATIONS

PATENTS & EXCLUSIVITIES

0

US Patents

0

US Exclusivities

GLOBAL SALES INFORMATION

Regulatory FDF Prices

NA

MARKET PLACE

DIGITAL CONTENT

0

Stock Recap #PipelineProspector

0

Weekly News Recap #Phispers

Chemistry

Click the arrow to open the dropdown
read-moreClick the button for full data set

FDA Orange Book

read-more
read-more

01

AMGEN INC

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

AMGEN INC

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

INFLIXIMAB-AXXQ

Brand Name : AVSOLA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/VIAL

Approval Date :

Application Number : 761086

RX/OTC/DISCN :

RLD :

TE Code :

blank

02

CELLTRION INC

South Korea
PEGS Boston Summit
Not Confirmed
arrow

CELLTRION INC

South Korea
arrow
PEGS Boston Summit
Not Confirmed

INFLIXIMAB-DYYB

Brand Name : INFLECTRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG

Approval Date :

Application Number : 125544

RX/OTC/DISCN :

RLD :

TE Code :

blank

03

CELLTRION

South Korea
PEGS Boston Summit
Not Confirmed
arrow

CELLTRION

South Korea
arrow
PEGS Boston Summit
Not Confirmed

INFLIXIMAB-DYYB

Brand Name : ZYMFENTRA

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 120MG/ML

Approval Date :

Application Number : 761358

RX/OTC/DISCN :

RLD :

TE Code :

blank

04

CENTOCOR INC

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

CENTOCOR INC

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

INFLIXIMAB

Brand Name : REMICADE

Dosage Form : VIAL

Dosage Strength : 100MG

Approval Date :

Application Number : 103772

RX/OTC/DISCN :

RLD :

TE Code :

blank

05

PFIZER INC

U.S.A
PEGS Boston Summit
Not Confirmed
arrow

PFIZER INC

U.S.A
arrow
PEGS Boston Summit
Not Confirmed

INFLIXIMAB-QBTX

Brand Name : IXIFI

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG/VIAL

Approval Date :

Application Number : 761072

RX/OTC/DISCN :

RLD :

TE Code :

blank

06

PEGS Boston Summit
Not Confirmed
arrow
arrow
PEGS Boston Summit
Not Confirmed

INFLIXIMAB-ABDA

Brand Name : RENFLEXIS

Dosage Form : INJECTABLE;INJECTION

Dosage Strength : 100MG

Approval Date :

Application Number : 761054

RX/OTC/DISCN :

RLD :

TE Code :

blank
Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Digital Content read-more

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

read-more
read-more

NEWS #PharmaBuzz

read-more
read-more

Global Sales Information

Do you need Business Intel? Ask us

Market Place

Do you need sourcing support? Ask us

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty